SICK LEAVE AND ITS PREDICTORS IN ANKYLOSING SPONDYLITIS: LONG-TERM RESULTS FROM THE OUTCOME IN ANKYLOSING SPONDYLITIS INTERNATIONAL STUDY

被引：0
|
作者：
Webers, C. [1 ,2 ]
Ramiro, S. [3 ]
Landewe, R. [4 ,5 ]
van der Heijde, D. [3 ]
van den Bosch, F. [6 ,7 ]
Dougados, M. [8 ,9 ]
van Tubergen, A. [1 ,2 ]
Boonen, A. [1 ,2 ]
机构：
[1] MUMC, Rheumatol, Maastricht, Netherlands
[2] CAPHRI, Maastricht, Netherlands
[3] LUMC, Rheumatol, Leiden, Netherlands
[4] Amsterdam Rheumatol Ctr, Rheumatol, Amsterdam, Netherlands
[5] Zuyderland Med Ctr, Rheumatol, Heerlen, Netherlands
[6] Ghent Univ Hosp, Rheumatol, Ghent, Belgium
[7] Univ Ghent, Ghent, Belgium
[8] Paris Descartes Univ, Rheumatol, Paris, France
[9] Cochin Hosp, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5141
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0233
引用
收藏
页码：336 / 336
页数：1
相关论文
共 50 条
  • [31] Long Term Outcome of Total Hip Replacement in Patients with Ankylosing Spondylitis
    Lizarraga, Ana
    Zamora, Natalia
    Betancur, Graciela
    Alejandro Cayetti, Luis
    Schneeberger, Emilce
    Celeste Orozco, Maria
    Andres Sommerfleck, Fernando
    Citera, Gustavo
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [32] Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
    Miguel Senabre-Gallego, Jose
    Santos-Ramirez, Carlos
    Santos-Soler, Gregorio
    Salas-Heredia, Esteban
    Sanchez-Barrioluengo, Mabel
    Barber, Xavier
    Rosas, Jose
    PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 961 - 972
  • [33] Long-term efficacy and safety of infliximab treatment of ankylosing spondylitis
    Boeger, CA
    Wittwer, H
    Schattenkirchner, M
    Kellner, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 64 - 64
  • [34] Understanding Presenteeism in Patients With Ankylosing Spondylitis: Contributing Factors and Association With Sick Leave
    Gordeev, Vladimir S.
    Maksymowych, Walter P.
    Schachna, Lionel
    Boonen, Annelies
    ARTHRITIS CARE & RESEARCH, 2014, 66 (06) : 916 - 924
  • [35] Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
    Elalouf, Ofir
    Elkayam, Ori
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1719 - 1726
  • [36] Impact of Ankylosing Spondylitis on Sick Leave, Presenteeism and Work Satisfaction in Turkish People
    Ozcan, Emel
    Sen, Ekin
    Esmaeilzadeh, Sina
    Rezvani, Aylin
    Baysak, Tugba
    Karan, Ayse
    Boonen, Annelies
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S505 - S506
  • [37] THE IMPACT OF ANKYLOSING SPONDYLITIS ON WORK IMPAIRMENT - RESULTS FROM THE SCOTLAND REGISTRY FOR ANKYLOSING SPONDYLITIS (SIRAS)
    Jones, G. T.
    Dean, L. E.
    Macfarlane, G. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 800 - 800
  • [38] The effect of concomitant ankylosing spondylitis on long-term outcome of patients with inflammatory bowel disease
    Atay, Kadri
    Eyvazov, Hayyam
    Bozcan, Selma
    Eskazan, Tugce
    Demir, Nurhan
    Hatemi, Ibrahim
    Erzin, Yusuf
    Celik, Aykut Ferhat
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 30 (07): : 599 - 604
  • [39] THE EFFECT OF SMOKING CESSATION IN ANKYLOSING SPONDYLITIS - RESULTS FROM THE SCOTLAND REGISTRY FOR ANKYLOSING SPONDYLITIS (SIRAS)
    Jones, G. T.
    Ratz, T.
    Dean, L. E.
    Macfarlane, G. J.
    Atzeni, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 773 - 773
  • [40] EARLY REFERRAL OF ANKYLOSING SPONDYLITIS PATIENTS: RESULTS OF ONE YEAR OUTCOME OF A SPECIALIZED EARLY ANKYLOSING SPONDYLITIS CLINIC
    El Miedany, Yasser
    Palmer, Deborah
    RHEUMATOLOGY, 2011, 50 : 145 - 145
12345